Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China flag China · Delayed Price · Currency is CNY
14.02
+0.03 (0.21%)
Mar 10, 2026, 3:00 PM CST
-2.16%
Market Cap 7.92B
Revenue (ttm) 3.13B
Net Income (ttm) 281.38M
Shares Out 566.16M
EPS (ttm) 0.49
PE Ratio 28.51
Forward PE 18.29
Dividend n/a
Ex-Dividend Date n/a
Volume 4,268,605
Average Volume 6,288,272
Open 14.00
Previous Close 13.99
Day's Range 13.90 - 14.12
52-Week Range 11.95 - 20.20
Beta 0.61
RSI 39.11
Earnings Date Apr 23, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China. [Read more]

Sector Healthcare
Founded 1975
Employees 6,132
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600557
Full Company Profile

Financial Performance

In 2024, SHA:600557's revenue was 3.90 billion, a decrease of -19.86% compared to the previous year's 4.86 billion. Earnings were 391.86 million, a decrease of -15.58%.

Financial Statements

News

There is no news available yet.